Earnings Call · Q3 FY2023·2023-11-08

Q3 23EPS +66.67%·Rev n/aQ2 23EPS +25.00%·Rev n/aQ1 23EPS +40.00%·Rev n/aQ4 22EPS 0.00%·Rev n/a⚠ consensus missing

Niagen Bioscience, Inc. NAGE

Kendall Knysch — Investor Relations

Rob Fried — Chief Executive Officer

Brianna Gerber — Chief Financial Officer

+4.6%1d on move date+4.5% vs SPY3d−10.5%5d−10.5%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more NAGE calls or request research access.

More NAGE calls Browse calls Request research access